Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation (Ike Swetlitz/Bloomberg)

Science Corp, the company behind a retinal chip that restores some vision to people with an age-related form of blindness, is valued at $3.5 billion after a recent fundraising round.

We haven't written up this one. Techmeme has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

More from Tuesday 17 November →